1. P488 Trends in corticosteroid (CS) use over time and following diagnosis in patients with Inflammatory Bowel Disease (IBD), using IBM® MarketScan®. (21st January 2022) Authors: Raine, T; Melmed, G Y; Finney-Hayward, T; Clark, R; Chapman, J C; Targownik, L; Burisch, J; Olen, O Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i454 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P716 A 2-week course of Exclusive Enteral Nutrition followed by the Crohn Disease Exclusion Diet is effective for Induction and Maintenance of Remission in children with Crohn Disease; the DIETOMICS-CD trial. (30th January 2023) Authors: Sigall-Boneh, R; Manuel Navas-López, V; Hussey, S; Pujol Muncunill, G; Lawrence, S; Jonsson Rolandsdotter, H; Otley, A; Martín-de-Carpi, J; Abramas, L; Herrador López, M; Egea Castillo, N; Chen, M; Hurley, M; Wingate, K; Olen, O; yaakov, M; Levine, A; Van Limbergen, J; Wine, E Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i845 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗